RNA interference against mixed lineage leukemia 5 resulted in cell cycle arrest

International Journal of Biochemistry and Cell Biology

Volumn 40, Issue 11, 2008, Pages 2472-2481

  Cheng, Fei ^a   Liu, Jie ^a   Zhou, Shun Hui ^a   Wang, Xiao Ning ^a   Chew, Jun Fang ^a   Deng, Lih Wen ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

G1 arrest; G2 M arrest; MLL5; p21; p53

Indexed keywords

BROXURIDINE; CYCLIN DEPENDENT KINASE INHIBITOR 1A; MIXED LINEAGE LEUKEMIA 5 PROTEIN; MIXED LINEAGE LEUKEMIA PROTEIN; PROTEIN P53; RETINOBLASTOMA PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE REGULATION; CELL GROWTH; CELL LINE; CONTROLLED STUDY; DIPLOIDY; FEMALE; GENE SILENCING; GROWTH INHIBITION; HUMAN; HUMAN CELL; PROTEIN DEPHOSPHORYLATION; RNA INTERFERENCE; TRANSACTIVATION; UPREGULATION;

ANIMALS; CELL CYCLE; CELL LINE; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DNA-BINDING PROTEINS; HUMANS; RETINOBLASTOMA PROTEIN; RNA INTERFERENCE; TUMOR SUPPRESSOR PROTEIN P53;

MAMMALIA;

EID: 48349133331     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2008.04.012     Document Type: Article

References (52)

1. Aasland R., Gibson T.J., and Stewart A.F. The PHD finger: implications for chromatin-mediated transcriptional regulation. Trends in Biochemical Science 20 (1995) 56-59
2. Adler H.T., Chinery R., Wu D.Y., Kussick S.J., Payne J.M., Fornace Jr. A.J., et al. Leukemic HRX fusion proteins inhibit GADD34-induced apoptosis and associate with the GADD34 and hSNF5/INI1 proteins. Molecular and Cellular Biology 19 (1999) 7050-7060
3. Ayton P.M., and Cleary M.L. Molecular mechanisms of leukemogenesis mediated by MLL fusion proteins. Oncogene 20 (2001) 5695-5707
4. Bunz F., Dutriaux A., Lengauer C., Waldman T., Zhou S., Brown J.P., et al. Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science 282 (1998) 1497-1501
5. Caslini C., Serna A., Rossi V., Introna M., and Biondi A. Modulation of cell cycle by graded expression of MLL-AF4 fusion oncoprotein. Leukemia 18 (2004) 1064-1071
6. Choi Y.H., Lee W.H., Park K.Y., and Zhang L. p53-independent induction of p21 (WAF1/CIP1), reduction of cyclin B1 and G2/M arrest by the isoflavone genistein in human prostate carcinoma cells. Japan Journal of Cancer Research 91 (2000) 164-173
7. Crook T., Tidy J.A., and H V.K. Degradation of p53 can be targeted by HPV E6 sequences distinct from those required for p53 binding and trans-activation. Cell 67 (1991) 547-556
8. Dahiya A., Wong S., Gonzalo S., Gavin M., and Dean D.C. Linking the Rb and polycomb pathways. Molecular Cell 8 (2001) 557-569
9. Deans A.J., Simpson K.J., Trivett M.K., Brown M.A., and McArthur G.A. Brca1 inactivation induces p27(Kip1)-dependent cell cycle arrest and delayed development in the mouse mammary gland. Oncogene 23 (2004) 6136-6145
10. Demers C., Chaturvedi C.P., Ranish J.A., Juban G., Lai P., Morle F., et al. Activator-mediated recruitment of the MLL2 methyltransferase complex to the beta-globin locus. Molecular Cell 27 (2007) 573-584
11. Deng C., Zhang P., Harper J.W., Elledge S.J., and Leder P. Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell 82 (1995) 675-684
12. Deng L.W., Chiu I., and Strominger J.L. MLL 5 protein forms intranuclear foci, and overexpression inhibits cell cycle progression. Proceedings of the National Academy of Science USA 101 (2004) 757-762
13. Djabali M., Selleri L., Parry P., Bower M., Young B.D., and Evans G.A. A trithorax-like gene is interrupted by chromosome 11q23 translocations in acute leukaemias. Nature Genetics 2 (1992) 113-118
14. Emerling B.M., Bonifas J., Kratz C.P., Donovan S., Taylor B.R., Green E.D., et al. MLL5, a homolog of Drosophila trithorax located within a segment of chromosome band 7q22 implicated in myeloid leukemia. Oncogene 21 (2002) 4849-4854
15. Ernst P., Wang J., and Korsmeyer S.J. The role of MLL in hematopoiesis and leukemia. Current Opinion in Hematology 9 (2002) 282-287
16. Evan G.I., and Vousden K.H. Proliferation, cell cycle and apoptosis in cancer. Nature 411 (2001) 342-348
17. Fair K., Anderson M., Bulanova E., Mi H., Tropschug M., and Diaz M.O. Protein interactions of the MLL PHD fingers modulate MLL target gene regulation in human cells. Molecular and Cellular Biology 21 (2001) 3589-3597
18. Fischer K., Frohling S., Scherer S.W., McAllister Brown J., Scholl C., Stilgenbauer S., et al. Molecular cytogenetic delineation of deletions and translocations involving chromosome band 7q22 in myeloid leukemias. Blood 89 (1997) 2036-2041
19. FitzGerald K.T., and Diaz M.O. MLL2: A new mammalian member of the trx/MLL family of genes. Genomics 59 (1999) 187-192
20. Giacinti C., and Giordano A. RB and cell cycle progression. Oncogene 25 (2006) 5220-5227
21. Gould A. Functions of mammalian polycomb group and trithorax group related genes. Current Opinion in Genetics and Development 7 (1997) 488-494
22. Gu Y., Nakamura T., Alder H., Prasad R., Canaani O., Cimino G., et al. The t(4;11) chromosome translocation of human acute leukemias fuses the ALL-1 gene, related to Drosophila trithorax, to the AF-4 gene. Cell 71 (1992) 701-708
23. Issaeva I., Zonis Y., Rozovskaia T., Orlovsky K., Croce C.M., Nakamura T., et al. Knockdown of ALR (MLL2) reveals ALR target genes and leads to alterations in cell adhesion and growth. Molecular and Cellular Biology 27 (2007) 1889-1903
24. Jacobs J.J., Kieboom K., Marino S., DePinho R.A., and van Lohuizen M. The oncogene and polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus. Nature 397 (1999) 164-168
25. Kim J.E., McAvoy S.A., Smith D.I., and Chen J. Human TopBP1 ensures genome integrity during normal S phase. Molecular and Cellular Biology 25 (2005) 10907-10915
26. Kittler R., Pelletier L., Heninger A.K., Slabicki M., Theis M., Miroslaw L., et al. Genome-scale RNAi profiling of cell division in human tissue culture cells. Nature Cell Biology 9 (2007) 1401-1412
27. Kong C.T., Sham M.H., So C.W., Cheah K.S., Chen S.J., and Chan L.C. The Mll-Een knockin fusion gene enhances proliferation of myeloid progenitors derived from mouse embryonic stem cells and causes myeloid leukaemia in chimeric mice. Leukemia 20 (2006) 1829-1839
28. Korenjak M., and Brehm A. E2F-Rb complexes regulating transcription of genes important for differentiation and development. Current Opinion in Genetics and Development 15 (2005) 520-527
29. Kouzarides T. Histone methylation in transcriptional control. Current Opinion in Genetics and Development 12 (2002) 198-209
30. Lee S., Lee D.-K., Dou Y., Lee J., Lee B., Kwak E., et al. Coactivator as a target gene specificity determinant for histone H3 lysine 4 methyltransferases. Proceedings of the National Academy of Science USA 103 (2006) 15392-15397
31. Liu H., Cheng E.H., and Hsieh J.J. Bimodal degradation of MLL by SCFSkp2 and APCCdc20 assures cell cycle execution: a critical regulatory circuit lost in leukemogenic MLL fusions. Genes and Development 21 (2007) 2385-2398
32. Lundberg A.S., and Weinberg R.A. Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes. Molecular and Cellular Biology 18 (1998) 753-761
33. MacLachlan T.K., Somasundaram K., Sgagias M., Shifman Y., Muschel R.J., Cowan K.H., et al. BRCA1 effects on the cell cycle and the DNA damage response are linked to altered gene expression. Journal of Biological Chemistry 275 (2000) 2777-2785
34. Macleod K.F., Sherry N., Hannon G., Beach D., Tokino T., Kinzler K., et al. p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage. Genes and Development 9 (1995) 935-944
35. Michieli P., Chedid M., Lin D., Pierce J.H., Mercer W.E., and Givol D. Induction of WAF1/CIP1 by a p53-independent pathway. Cancer Research 54 (1994) 3391-3395
36. Milne T.A., Briggs S.D., Brock H.W., Martin M.E., Gibbs D., Allis C.D., et al. MLL targets SET domain methyltransferase activity to Hox gene promoters. Molecular Cell 10 (2002) 1107-1117
37. Milutinovic S., Zhuang Q., Niveleau A., and Szyf M. Epigenomic stress response. Knockdown of DNA methyltransferase 1 triggers an intra-S-phase arrest of DNA replication and induction of stress response genes. Journal of Biological Chemistry 278 (2003) 14985-14995
38. Nakamura T., Mori T., Tada S., Krajewski W., Rozovskaia T., Wassell R., et al. ALL-1 is a histone methyltransferase that assembles a supercomplex of proteins involved in transcriptional regulation. Molecular Cell 10 (2002) 1119-1128
39. Niculescu III A.B., Chen X., Smeets M., Hengst L., Prives C., and Reed S.I. Effects of p21(Cip1/Waf1) at both the G1/S and the G2/M cell cycle transitions: pRb is a critical determinant in blocking DNA replication and in preventing endoreduplication. Molecular and Cellular Biology 18 (1998) 629-643
40. Nightingale K.P., Gendreizig S., White D.A., Bradbury C., Hollfelder F., and Turner B.M. Cross-talk between histone modifications in response to histone deacetylase inhibitors: MLL4 links histone H3 acetylation and histone H3K4 methylation. Journal of Biological Chemistry 282 (2007) 4408-4416
41. Prasad R., Zhadanov A.B., Sedkov Y., Bullrich F., Druck T., Rallapalli R., et al. Structure and expression pattern of human ALR, a novel gene with strong homology to ALL-1 involved in acute leukemia and to Drosophila trithorax. Oncogene 15 (1997) 549-560
42. Richon V.M., Sandhoff T.W., Rifkind R.A., and Marks P.A. Histone deacetylase inhibitor selectively induces p21WAF1 expression and gene-associated histone acetylation. Proceedings of the National Academy of Science USA 97 (2000) 10014-10019
43. Ruault M., Brun M.E., Ventura M., Roizes G., and De Sario A. MLL3, a new human member of the TRX/MLL gene family, maps to 7q36, a chromosome region frequently deleted in myeloid leukaemia. Gene 284 (2002) 73-81
44. Schuettengruber B., Chourrout D., Vervoort M., Leblanc B., and Cavalli G. Genome regulation by polycomb and trithorax proteins. Cell 128 (2007) 735-745
45. Sherr C.J., and Roberts J.M. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes and Development 13 (1999) 1501-1512
46. Simon J.A., and Tamkun J.W. Programming off and on states in chromatin: mechanisms of polycomb and trithorax group complexes. Current Opinion in Genetics and Development 12 (2002) 210-218
47. Thomas M., Pim D., and Banks L. The role of the E6-p53 interaction in the molecular pathogenesis of HPV. Oncogene 18 (1999) 7690-7700
48. Tyagi S., Chabes A.L., Wysocka J., and Herr W. E2F activation of S phase promoters via association with HCF-1 and the MLL family of histone H3K4 methyltransferases. Molecular Cell 27 (2007) 107-119
49. Vermeulen K., Van Bockstaele D.R., and Berneman Z.N. The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer. Cell Proliferation 36 (2003) 131-149
50. Waldman T., Kinzler K.W., and Vogelstein B. p21 is necessary for the p53-mediated G1 arrest in human cancer cells. Cancer Research 55 (1995) 5187-5190
51. Xiong Y., Hannon G., Zhang H., Casso D., Kobayashi R., and Beach D. p21 is a universal inhibitor of cyclin kinases. Nature 366 (1993) 701-704
52. Xiong Y., Zhang H., and Beach D. D type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA. Cell 71 (1992) 505-514